Azzad Asset Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,180
Closed -$228K 309
2023
Q4
$228K Buy
2,180
+49
+2% +$4.78K 0.03% 296
2023
Q3
$224K Sell
2,131
-110
-5% -$14.1K 0.03% 294
2023
Q2
$288K Buy
2,241
+75
+3% +$11.4K 0.04% 301
2023
Q1
$378K Buy
2,166
+68
+3% +$12.2K 0.05% 288
2022
Q4
$349K Buy
2,098
+13
+0.6% +$2.04K 0.06% 284
2022
Q3
$294K Buy
2,085
+16
+0.8% +$2.92K 0.03% 374
2022
Q2
$422K Sell
2,069
-7
-0.3% -$1.53K 0.04% 344
2022
Q1
$529K Buy
+2,076
New +$564K 0.08% 275

Other funds holding MLAB

Azzad Asset Management's MLAB Position: Q1 2024 in Review

Azzad Asset Management sold out of Mesa Laboratories (MLAB) in Q1 2024, closing a stake of 2,180 shares — an estimated $228K sold.

Azzad Asset Management first reported a position in MLAB in Q1 2022 and held it in 8 quarters. The position peaked at $529K in Q1 2022. 155 funds tracked by Wall St. Rank hold MLAB as of Q1 2024.

  • Azzad Asset Management reported no remaining Mesa Laboratories position as of Q1 2024 after selling out during the quarter.
  • Azzad Asset Management sold 2,180 Mesa Laboratories shares in Q1 2024, an estimated $228K.
  • Azzad Asset Management first reported a position in Mesa Laboratories in Q1 2022 and held it in 8 quarters.
  • Azzad Asset Management's Mesa Laboratories position peaked at $529K in Q1 2022.
  • 155 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2024.

Based on Azzad Asset Management's 13F filing for Q1 2024, filed 19 Apr 2024.